Glucose transporter type1 (GLUT-1) deficiency

Brain Dev. 2003 Oct;25(7):477-80. doi: 10.1016/s0387-7604(03)00058-5.

Abstract

Glucose transporter type1 (GLUT-1) deficiency may be rare, but it is a preventable cause of severe learning difficulties; and therefore there is an urgency in making an early diagnosis. Suspicions must be roused when intractable seizures occur in infancy. These may be associated with acquired microcephaly and developmental delay. The finding of low glucose sugar levels in the cerebrospinal fluid, but not in the blood will identify the condition. The gene encoding the GLUT-1 protein is located on the short arm of chromosome 1, and inheritance is by a dominant trait. Patients with this syndrome can have heterozygous mutations, with one allele being a normal wild type and one being mutant. An efficient transport of glucose across the blood-brain barrier is essential as it is such an important fuel for the brain, and this is provided by glucose transporter type1 in the endothelial cells of the brain capillaries. Another minor contribution to the symptomatology of GLUT-1 may be impaired transport of an oxidised form of vitamin C. Treatment with anti-epileptic drugs may be needed, and the ketogenic diet may reduce symptoms, as ketosis can provide an alternative source of fuel for the brain. It has also been suggested that antioxidant thioctic acid may be of benefit. Substances such as caffeine and phenobarbitone should be avoided as they inhibit glucose transport.

Publication types

  • Review

MeSH terms

  • Anticonvulsants / adverse effects
  • Anticonvulsants / therapeutic use
  • Antioxidants / therapeutic use
  • Ascorbic Acid / metabolism
  • Blood-Brain Barrier / physiopathology
  • Caffeine / adverse effects
  • Central Nervous System Stimulants / adverse effects
  • Chromosomes, Human, Pair 1
  • Glucose / cerebrospinal fluid
  • Glucose Transporter Type 1
  • Humans
  • Ketosis / etiology
  • Learning Disabilities / etiology*
  • Learning Disabilities / metabolism
  • Monosaccharide Transport Proteins / deficiency*
  • Mutation
  • Phenobarbital / adverse effects
  • Seizures / etiology
  • Thioctic Acid / therapeutic use

Substances

  • Anticonvulsants
  • Antioxidants
  • Central Nervous System Stimulants
  • Glucose Transporter Type 1
  • Monosaccharide Transport Proteins
  • SLC2A1 protein, human
  • Caffeine
  • Thioctic Acid
  • Glucose
  • Ascorbic Acid
  • Phenobarbital